Adagio Medical Holdings (ADGM) Net Income towards Common Stockholders (2023 - 2026)
Adagio Medical Holdings (ADGM) posted Net Income towards Common Stockholders of -$6.8 million for Q1 2026, down 47.56% sequentially from -$4.6 million in Q4 2025, and up 26.34% YoY from -$5.4 million in Q1 2025.
Adagio Medical Holdings (ADGM) Net Income towards Common Stockholders (2023 - 2026) Analysis & Trends
Adagio Medical Holdings has reported Net Income towards Common Stockholders for 4 years, with the latest figure at -$6.8 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 26.34% year-over-year to -$6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$28.0 million (up 40.29% YoY) and the FY2025 annual result came in at -$25.1 million, up 53.34% from the prior year.
- Net Income towards Common Stockholders slipped to -$6.8 million in Q1 2026 per ADGM's latest filing, from -$4.6 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at -$4.6 million in Q4 2025 and troughed at -$33.0 million in Q2 2024.
- A 4-year average of -$10.1 million and a median of -$8.0 million in 2025 frame the typical range for Net Income towards Common Stockholders.
- The widest YoY moves for Net Income towards Common Stockholders: up 83.81% in 2025, down 137.15% in 2025.
- Over 4 years, Net Income towards Common Stockholders stood at -$6.4 million in 2023, then rose by 25.54% to -$4.8 million in 2024, then advanced by 3.11% to -$4.6 million in 2025, then tumbled by 47.56% to -$6.8 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$6.8 million, -$4.6 million, and -$11.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Adagio Medical Holdings | 14.11 Mn | 14.11 Mn | - | -5.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.23 Mn |
| Mar 31, 2026 | -6.80 Mn |
| Dec 31, 2025 | -4.61 Mn |
| Sep 30, 2025 | -11.29 Mn |
| Jun 30, 2025 | -5.34 Mn |
| Mar 31, 2025 | -9.24 Mn |
| Sep 30, 2024 | -4.76 Mn |
| Jun 30, 2024 | -32.96 Mn |
| Mar 31, 2024 | -9.57 Mn |
| Dec 31, 2023 | -6.39 Mn |
| Sep 30, 2023 | -9.56 Mn |